Current position:Home >Product >
2-[9-(2-morpholin-4-ylethyl)-3,4-dihydro-1H-pyrido[3,4-b]indol-2-yl]-N-oxidanyl-pyrimidine-5-carboxamide
2-[9-(2-morpholin-4-ylethyl)-3,4-dihydro-1H-pyrido[3,4-b]indol-2-yl]-N-oxidanyl-pyrimidine-5-carboxamide
|
|
Canonical SMILES:
C1CN(CC2=C1C3=CC=CC=C3N2CCN4CCOCC4)C5=NC=C(C=N5)C(=O)NO
Isomeric SMILES
C1CN(CC2=C1C3=CC=CC=C3N2CCN4CCOCC4)C5=NC=C(C=N5)C(=O)NO
InChI
InChI=1S/C22H26N6O3/c29-21(25-30)16-13-23-22(24-14-16)27-6-5-18-17-3-1-2-4-19(17)28(20(18)15-27)8-7-26-9-11-31-12-10-26/h1-4,13-14,30H,5-12,15H2,(H,25,29)
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- N-oxidanyl-2-[9-(phenylsulfonyl)-3,4-dihydro-1H-pyrido[3,4-b]indol-2-yl]pyrimidine-5-carboxamide
- 2-[5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-pyrazol-3-yl]-5-cyclobutyl-1,3,4-oxadiazole
- 2-[5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-pyrazol-3-yl]-5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazole
- 5-[5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-pyrazol-3-yl]-N,N-dimethyl-1,3,4-oxadiazol-2-amine
- 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-(5-propyl-1,3,4-oxadiazol-2-yl)pyrazole-4-carbonitrile
- 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-(5-propan-2-yl-1,3,4-oxadiazol-2-yl)pyrazole-4-carbonitrile
- 3-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)pyrazole-4-carbonitrile
- 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-[5-(3-phenylpropyl)-1,3,4-oxadiazol-2-yl]pyrazole-4-carbonitrile
- 3-azanyl-6-chloranyl-5-[(3S)-4-[1-[[4-cyano-2-(2-hydroxyethyloxy)phenyl]methyl]piperidin-4-yl]-3-ethyl-piperazin-1-yl]-N-cyclopropyl-pyrazine-2-carboxamide
- 3-azanyl-6-chloranyl-5-[(3S)-4-[1-[[4-chloranyl-2-(2-hydroxyethyl)phenyl]methyl]piperidin-4-yl]-3-ethyl-piperazin-1-yl]pyrazine-2-carboxamide

